{"id":"W1488386819","doi":"10.1002/cncr.28766","title":"Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Axitinib; Thyroid cancer; Internal medicine; Cancer; Adverse effect; Pharmacodynamics; Population; Quality of life (healthcare); Medullary thyroid cancer; Clinical endpoint; Pharmacokinetics; Clinical trial; Oncology; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00413092,0.001081811,0.00121205,0.0003978621,0.0003281832,0.0007229008,0.0005734477,0.0007411873,0.002111393],"category_scores_gemma":[0.001137907,0.0003575444,0.0013082,0.0005926845,0.0007349955,0.0004676846,0.0005153114,0.00200074,0.0003619779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001320838,"about_ca_system_score_gemma":0.001692092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001301758,"about_ca_topic_score_gemma":0.001797948,"domain_scores_codex":[0.9990872,0.0004675293,0.00003963371,0.0001078875,0.0001862886,0.0001113876],"domain_scores_gemma":[0.9990621,0.0001077562,0.0002813297,0.00007666095,0.00009213783,0.0003799956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5658783,0.1257976,0.07743233,0.001077384,0.004384343,0.0002877172,0.0005575326,0.005573128,0.0514539,0.000307892,0.004503063,0.1627468],"study_design_scores_gemma":[0.3460178,0.503846,0.1374178,0.00004787499,0.001004645,0.0005492055,0.00008047244,0.003586598,0.003890514,0.0002706035,0.003220154,0.00006829106],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955675,0.001167063,0.000490933,0.0001726441,0.00002124923,0.00121979,0.0005003381,0.00003600181,0.0008245294],"genre_scores_gemma":[0.9923708,0.0007743327,0.001697386,0.000450593,0.00008126883,0.002281146,0.001625381,0.00001172389,0.0007073075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00413092,"threshold_uncertainty_score":0.02184665,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03737203276533978,"score_gpt":0.4206336851554701,"score_spread":0.3832616523901303,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}